SEI Investments’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

SEI Investments’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-941	Closed	-$51K	–	3157
2018 Q2	$51K	Hold	941	–	–	﹤0.01%	2509
2018 Q1	$46K	Hold	941	–	–	﹤0.01%	2386
2017 Q4	$44K	Hold	941	–	–	﹤0.01%	2398
2017 Q3	$47K	Hold	941	–	–	﹤0.01%	2294
2017 Q2	$43K	Buy	941 +181	+24%	+$7.81K	﹤0.01%	2281
2017 Q1	$32K	Hold	760	–	–	﹤0.01%	2237
2016 Q4	$30K	Hold	760	–	–	﹤0.01%	2259
2016 Q3	$32K	Buy	+760	New	+$31.2K	﹤0.01%	2167

Other funds holding PBE

ACM

Arlington Capital Management Arlington Heights, Illinois $177M AUM 44.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CAS

Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return

AFM

Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return

SEI Investments's PBE Position: Q3 2018 in Review

SEI Investments sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2018, closing a stake of 941 shares — an estimated $51K sold.

SEI Investments first reported a position in PBE in Q3 2016 and held it in 8 quarters. The position peaked at $51K in Q2 2018. 74 funds tracked by Wall St. Rank hold PBE as of Q3 2018.

SEI Investments reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 941 Invesco Biotechnology & Genome ETF shares in Q3 2018, an estimated $51K.
SEI Investments first reported a position in Invesco Biotechnology & Genome ETF in Q3 2016 and held it in 8 quarters.
SEI Investments's Invesco Biotechnology & Genome ETF position peaked at $51K in Q2 2018.
74 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.